Intellia Therapeutics Inc - NTLA - stock price prediction, stock price target, analyst ratings from 29 analysts

Intellia Therapeutics Inc has a share price target of US$ 37, revenue growth forecast of -3.2%, and profit growth estimate of 16.4% for FY25, based on top 29 analyst calls.